• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肯尼亚乌干达县 2019 年冠状病毒病疫苗接种后不良事件报告最佳实践的实施。

Best practice implementation on reporting of coronavirus disease 2019 vaccine adverse events following immunization in Uasin Gishu County, Kenya.

机构信息

Uasin Gishu County Hospital.

Huruma Sub County Hospital, Eldoret, Kenya.

出版信息

JBI Evid Implement. 2023 Jun 1;21(2):146-155. doi: 10.1097/XEB.0000000000000362.

DOI:10.1097/XEB.0000000000000362
PMID:36545897
Abstract

OBJECTIVES

This project's aim was to implement vaccine safety surveillance best practices to improve reporting of adverse events following immunization (AEFI) during coronavirus disease 2019 (COVID-19) vaccination roll out in Uasin Gishu County.

INTRODUCTION

Weak vaccine safety surveillance systems in developing countries has contributed to underreporting of AEFIs undermining public confidence in immunization efforts, contributing to low uptake of vaccines critical in the fight against communicable diseases.

METHODS

The JBI Practical Application of Clinical Evidence System (JBI PACES) and Getting Research into Practice (GRiP) audit tool for promoting change in healthcare practice was utilized. Preimplementation and postimplementation audit cycles carried out utilized six best practice recommendations. Context-specific strategies and resources were used to address the gaps identified.

RESULTS

Less than half of the AEFIs reported were in accordance with the local policy recommendation, and most of the AEFIs reported were submitted in a timely manner in the baseline and follow-up cycle. Slight improvement was recorded in the number of health facilities with AEFIs reporting forms. An improvement of 33.7% was recorded in the number of health workers providing COVID-19 vaccination services who had received education and practical training on vaccine pharmacovigilance.

CONCLUSION

Underreporting and delayed submission of COVID-19 vaccine AEFI was evident among the healthcare providers offering COVID-19 vaccination services, the majority of healthcare providers had received training on vaccine pharmacovigilance, and AEFI hard copy reporting forms were not adequate in the health facilities. Public education on vaccine safety before administration of vaccine needs emphasis in order to improve reporting of AEFI.

摘要

目的

本项目旨在实施疫苗安全监测最佳实践,以改善在 Uasin Gishu 县开展 2019 年冠状病毒病(COVID-19)疫苗接种期间对疫苗接种后不良反应(AEFI)的报告。

简介

发展中国家薄弱的疫苗安全监测系统导致 AEFI 报告不足,破坏了公众对免疫工作的信心,导致对抗传染病至关重要的疫苗接种率低。

方法

利用 JBI 临床实践证据系统(JBI PACES)和促进医疗实践变革的获取研究实践(GRiP)审核工具。在实施前和实施后审核周期中,利用了六项最佳实践建议。使用特定于上下文的策略和资源来解决确定的差距。

结果

报告的 AEFI 中,不到一半符合当地政策建议,且大多数报告的 AEFI 都在基线和随访周期中及时提交。在报告 AEFI 的卫生机构数量方面,记录到略有改善。接受 COVID-19 疫苗药物警戒教育和实践培训的提供 COVID-19 疫苗接种服务的卫生工作者人数增加了 33.7%。

结论

提供 COVID-19 疫苗接种服务的卫生保健提供者中存在 AEFI 报告不足和延迟提交的情况,大多数卫生保健提供者已经接受了疫苗药物警戒培训,且卫生机构中缺乏 AEFI 纸质报告表。在接种疫苗之前,需要对公众进行疫苗安全性教育,以提高 AEFI 的报告率。

相似文献

1
Best practice implementation on reporting of coronavirus disease 2019 vaccine adverse events following immunization in Uasin Gishu County, Kenya.肯尼亚乌干达县 2019 年冠状病毒病疫苗接种后不良事件报告最佳实践的实施。
JBI Evid Implement. 2023 Jun 1;21(2):146-155. doi: 10.1097/XEB.0000000000000362.
2
Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.描述四种不同 COVID-19 疫苗品牌接种后报告的不良事件频率。
Drug Saf. 2022 Apr;45(4):319-331. doi: 10.1007/s40264-022-01151-w. Epub 2022 Mar 21.
3
Leveraging COVID-19 Vaccine Safety Monitoring in Ethiopia and Pakistan to Enhance System-Wide Safety Surveillance.利用埃塞俄比亚和巴基斯坦的 COVID-19 疫苗安全监测来加强全系统安全监测。
Glob Health Sci Pract. 2024 Feb 20;12(Suppl 1). doi: 10.9745/GHSP-D-23-00161.
4
[Adverse events following immunization reported with COVID-19 vaccines in Burkina Faso: Analysis of spontaneous reports].[布基纳法索新冠疫苗接种后的不良事件:自发报告分析]
Sante Publique. 2024 Feb 23;35(6):149-159. doi: 10.3917/spub.236.0149.
5
Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.人们对接种疫苗的意愿受到他人接种后不良反应的影响。
Vaccine. 2023 Jan 4;41(1):246-250. doi: 10.1016/j.vaccine.2022.11.034. Epub 2022 Nov 26.
6
Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.疫苗不良事件自动报告系统中报告的与 2019 年冠状病毒病疫苗接种相关的不良事件。
J Korean Med Sci. 2021 May 3;36(17):e114. doi: 10.3346/jkms.2021.36.e114.
7
Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial.短信移动医疗(SMS m-Health)在资源有限环境下用于免疫接种后不良反应(AEFIs)检测的效果和可行性:津巴布韦刺激电话辅助快速安全监测(Zm-STARSS)随机对照试验。
Vaccine. 2023 Oct 26;41(45):6700-6709. doi: 10.1016/j.vaccine.2023.09.037. Epub 2023 Oct 5.
8
COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study.COVID-19 mRNA 疫苗:一项回顾性观察性药物警戒研究。
Clin Drug Investig. 2022 Dec;42(12):1065-1074. doi: 10.1007/s40261-022-01216-9. Epub 2022 Oct 23.
9
Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.对“SAEFVIC”的评估,这是澳大利亚维多利亚州一项针对免疫接种后不良事件自发报告的药物警戒监测计划。
Drug Saf. 2017 Jun;40(6):483-495. doi: 10.1007/s40264-017-0520-7.
10
Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands.荷兰 COVID-19 基础免疫和加强免疫后自发报告的不良事件。
Vaccine. 2023 Jun 29;41(29):4319-4326. doi: 10.1016/j.vaccine.2023.05.053. Epub 2023 May 24.